Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 May 27:2018:7273420.
doi: 10.1155/2018/7273420. eCollection 2018.

Lethal End of Spectrum of Clots-Thrombotic Storm

Affiliations
Case Reports

Lethal End of Spectrum of Clots-Thrombotic Storm

Muhammad Asim Rana et al. Case Rep Crit Care. .

Abstract

Thrombotic storm (TS) is a rare, acute, hypercoagulable state characterized by multiple thromboembolic events affecting at least two different areas of the vascular system/organs over a short period of time. Typical triggers include inflammation, infections, minor trauma, surgery, pregnancy, and the puerperium. A single thrombotic event can set off a number of thromboembolic events, often including unusual locations like hepatic, portal, or renal veins, skin (purpura fulminans), adrenal glands, and cerebral sinus venous thrombosis. Usually, younger female patients are affected; in some patients, there is an association with an autoimmune disorder like lupus erythematosus, and they show evidence of antiphospholipid antibodies or other phenotypic expressions of anticoagulation disorders. The majority of patients have no previous history of thromboembolism. As the diagnosis of thrombotic storm relies solely on clinical symptoms with a lack of specific diagnostic tests, this can result in a delay of diagnosis. The treatment consists of uninterrupted lifelong anticoagulation. Sometimes immunomodulatory therapies have been used. The distinction between extensive thrombotic events like Heparin Induced Thrombosis (HIT), Thrombotic Thrombocytopenic Purpura (TTP), Antiphospholipids Syndrome (APS), and TS can sometimes be difficult, and the etiology of TS remains uncertain.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CECT PE Protocol showing bilateral massive pulmonary embolism (yellow arrows). CECT abdomen showing infarction in spleen (c). In (d), partly infarcted right and totally infarcted kidneys are also seen with partial opacification of inferior vena cava (d).
Figure 2
Figure 2
CECT abdomen showing partial infarction of the right kidney, totally nonperfused hypodense (completely infarcted) left kidney with thrombosis of distal left renal artery and proximal left renal vein. Inferior vena cava is seen partially filled with contrast (a, b) while nonenhancement is evident in distal to left renal vein. Thrombosis of inferior vena cava is seen extending into bilateral internal and external iliac veins and then into bilateral femoral veins (yellow arrows) (c, d).
Figure 3
Figure 3
Loss of flow signal intensity in left lateral sinus which is showing heterogeneous appearance on FLAIR and T2-weighted images suggesting left lateral sinus thrombosis with venous infarction.

References

    1. Kitchens C. S., Erkan D., Brando L. R., et al. Thrombotic storm revisited: Preliminary diagnostic criteria suggested by the thrombotic storm study group. American Journal of Medicine. 2011;124(4):290–296. doi: 10.1016/j.amjmed.2010.10.018. - DOI - PubMed
    1. Kitchens C. S. Thrombotic storm: when thrombosis begets thrombosis. American Journal of Medicine. 1998;104(4):381–385. doi: 10.1016/s0002-9343(98)00061-8. - DOI - PubMed
    1. Piccin A., Murphy C., Eakins E., et al. Protein C and free protein S in children with sickle cell anemia. Annals of Hematology. 2012;91(10):1669–1671. doi: 10.1007/s00277-012-1447-9. - DOI - PubMed
    1. Piccin A., Dossi R. C., Cassibba V., Stupnner S., Bonatti G., Cortelazzo S. Anti-thrombin-III reduction and posterior reversible encephalopathy syndrome (PRES) in acute lymphoblastic leukaemia (ALL). New insight into PRES pathophysiology. Annals of Hematology. 2012;91(7):1153–1155. doi: 10.1007/s00277-011-1376-z. - DOI - PubMed
    1. Piccin A., Sartori M. T., Bisogno G., et al. New insights into sinusoidal obstruction syndrome. Internal Medicine Journal. 2017;47(10):1173–1183. doi: 10.1111/imj.13550. - DOI - PubMed

Publication types

LinkOut - more resources